Literature DB >> 20924551

[Kapandji-Sauvé procedure with distal radioulnar fusion and segmental resection of the ulna].

H Haferkamp1.   

Abstract

OBJECTIVE: The Kapandji-Sauvé procedure aims at improvement of rotation in the distal radioulnar joint and reduction of pain. Cases of ulnar impaction syndrome can also be corrected during the same procedure. INDICATIONS: The most important indication is painful und restricted forearm rotation after fracture of the distal radius combined with obsolete dislocation or destruction of the distal radioulnar joint. CONTRAINDICATIONS: It is a salvage procedure and is contraindicated when reconstruction of the radioulnar joint or shortening of the ulna is possible. Further contraindications are rheumatic arthritis and osteoporosis. SURGICAL TECHNIQUE: The Kapandji-Sauvé procedure creates a new distal rotatory joint due to distal radioulnar fusion and segmental resection of the distal ulna. POSTOPERATIVE MANAGEMENT: Forearm cast including the wrist for 3-4 weeks. Phyisiotherapy and intensive exercises of the fingers on postoperative day 1. After removing the cast, careful rotation exercises are possible.
RESULTS: In 75 patients, the Kapandji-Sauvé procedure was performed between 1990 and 2003. Failure was observed in one patient with a bony regeneration between the resected ulnar segment. In 3 cases, a nonunion of the radioulnar joint was found. After revision with bone grafting, bony consolidation of the joint was identified in all cases. In 2 cases, there were problems with the proximal ulnar stump, whereby this was corrected in one case by resection of a ball-type callus. In the other case, painful ulna-snapping was reduced by shortening of the ulna. In earlier follow-up with 45 patients and later long-turn follow-up, ranging from 3-12 years, not only were significant improvement of forearm rotation and reduction of pain observed, but also good patient satisfaction was found.

Entities:  

Mesh:

Year:  2012        PMID: 20924551     DOI: 10.1007/s00064-010-8044-7

Source DB:  PubMed          Journal:  Oper Orthop Traumatol        ISSN: 0934-6694            Impact factor:   1.154


  7 in total

1.  [Distal radio-ulnar arthrodesis and Kapandji ulna segment resection in treatment of limited forearm rotation].

Authors:  P Preisser; D Buck-Gramcko; J Hess
Journal:  Handchir Mikrochir Plast Chir       Date:  1991-09       Impact factor: 1.018

2.  [Results of Kapandji-Sauvé operation after distal radius fractures].

Authors:  N Borisch; P Haussmann
Journal:  Handchir Mikrochir Plast Chir       Date:  1998-11       Impact factor: 1.018

3.  [Late outcome of Kapandji-Sauvé distal radio-ulnar arthrodesis].

Authors:  E Welk; A K Martini
Journal:  Handchir Mikrochir Plast Chir       Date:  1998-11       Impact factor: 1.018

4.  [Results of Kapandji-Sauvé procedure with distal radio-ulnar fusion and segmental resection of the ulna].

Authors:  H Haferkamp; B Heidemann; O Gühne; B Deventer
Journal:  Handchir Mikrochir Plast Chir       Date:  2003-05       Impact factor: 1.018

5.  [Clinical long-term outcome after Kapandji-Sauvé procedure].

Authors:  R Zimmermann; M Gschwentner; R Arora; M Gabl; S Pechlaner
Journal:  Handchir Mikrochir Plast Chir       Date:  2003-05       Impact factor: 1.018

6.  [Functional results after the Kapandji-Sauvé operation for salvage of the distal radioulnar joint].

Authors:  C Czermak; M Wittemann; G Germann; M Sauerbier
Journal:  Handchir Mikrochir Plast Chir       Date:  2007-12       Impact factor: 1.018

7.  [Wrist para-articular radioulnar arthrodesis with distal Kapandji ulnar resection].

Authors:  H Haferkamp
Journal:  Handchir Mikrochir Plast Chir       Date:  1994-11       Impact factor: 1.018

  7 in total
  2 in total

1.  [Interventions on the wrist joint].

Authors:  K-J Prommersberger
Journal:  Oper Orthop Traumatol       Date:  2011-04       Impact factor: 1.154

Review 2.  [Malformations of hand and forearm : Conspicuous postpartum].

Authors:  F Unglaub; M F Langer; P Hahn; L P Müller; F Cakmak; C K Spies
Journal:  Orthopade       Date:  2016-07       Impact factor: 1.087

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.